<DOC>
<DOCNO>
EP-0013017
</DOCNO>
<TEXT>
<DATE>
19800709
</DATE>
<IPC-CLASSIFICATIONS>
A61K-31/395 C07C-237/06 A61K-31/165 A61P-31/00 C07D-295/00 C07C-237/04 C07D-295/145 A61K-31/16 A61P-31/12 C07D-295/15 C07C-237/00 
</IPC-CLASSIFICATIONS>
<TITLE>
4-homoisotwistane-aminoacid amides and pharmaceutical compositions containing same.
</TITLE>
<APPLICANT>
kao corpjp<sep>sumitomo chem indjp<sep>kao soap company, limited<sep>sumitomo chemical industries ltd. <sep>kao corporation 1-14-10, nihonbashikayaba-cho, chuo-kutokyojp<sep>sumitomo chemical industries ltd.15, kitahama 5 chomehigashi-ku, osaka-shijp<sep>
</APPLICANT>
<INVENTOR>
inamoto yoshiakijp<sep>kashihara eijijp<sep>osugi motoyoshijp<sep>inamoto, yoshiaki<sep>kashihara, eiji<sep>osugi, motoyoshi<sep>inamoto, yoshiaki970-63 himurochoutsunomiya-shi tochigijp<sep>kashihara, eiji1130, nishihamawakayama-shi wakayamajp<sep>osugi, motoyoshi1130, nishihamawakayama-shi wakayamajp<sep>
</INVENTOR>
<ABSTRACT>
4-homoisotwistane-aminoacid amides having the for­ mula    wherein a is 0 or 1, r₁ is hydrogen or lower alkyl, a is lower  alkylene or lower alkylidene, and r₂ and r₃, which can be the  same or different, are hydrogen, lower alkyl, cycloalkyl, ben­ zyl or substituted benzyl, or    is a saturated heterocyclic ring, acid addition salts thereof and  pharmaceutical compositions containing same, possess  anti-viral activity and reduced activity on the central nervous  system.  
</ABSTRACT>
</TEXT>
</DOC>
